MEI Pharma Inc (MEIP)
2.36
-0.14
(-5.60%)
USD |
NASDAQ |
Dec 23, 16:00
MEI Pharma Cash from Investing (Quarterly): 14.70M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Evoke Pharma Inc | -- |
| Revance Therapeutics Inc | 23.29M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.713M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.45M |
| Free Cash Flow | -43.43M |
| Free Cash Flow Per Share (Quarterly) | -1.718 |
| Free Cash Flow Yield | -276.2% |